Atlas Trials

Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment

Clinical trial NCT04706949 · UNKNOWN

Trial details

NCT number
NCT04706949
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer, Non-small Cell
Start date
2020-12-07
Primary completion
2021-12-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.